Available Trials
- CRASH: Corticosteriod Randomisation after Significant Head Injury
- CRASH2: Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
- CRASH-3: Effect of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury: a randomised, placebo-controlled trial
- HALT-IT Trial: Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
- WOMAN Trial: Tranexamic acid for the treatment of postpartum haemorrhage: an international randomised double blind placebo controlled trial
- WOMAN ETAC: Effects of tranexamic acid of coagulation and fibrinolysis in women with post partum haemorrhage
- WOMAN ETAPLAT: Effect of tranexamic acid of platelet function and thrombin generation in a sample of participants in the WOMAN trial
- WOMAN 483 deaths: clinical and contextual factors surrounding the deaths of 483 women following post-partum haemorrhage in developing countries
- WOMAN-2 Pilot Study: Pilot Study to test outcome questions for the WOMAN-2 trial of tranexamic acid for the prevention of postpartum haemorrhage
- Trauma Intact: Pharmacokinetics of intramuscular tranexamic acid in trauma patients: a clinical trial
- PharmacoTXA: Pharmacokinetics of Tranexamic Acid after oral, intramuscular or intravenous administration: a prospective, randomised, cross-over trial in healthy volunteers
Back to home page